Considering that the accumulation of pS129-α-syn is found in the majority of PD cases and other pathological conditions (2, 61), our findings also suggest that improving parkin phosphorylation could be a promising therapeutic approach for treating PD and other diseases associated with Lewy bodies or the accumulation of toxic pS129-α-syn. Here, PRKN is linked to Parkinson disease.